Newsroom

Infographic
Story
The Helmholtz Institute for One Health is a new HZI location in Greifswald, linking research into human and animal health with environmental factors.
04.10.2021
Gruppenbild
News
It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University will work together even more closely in the future. To this end, they have now founded the Translational Centre for Bioactive Compounds, in which scientists from both institutions will interact closely with the University Hospital in Homburg and the pharmaceutical industry.
02.10.2021
Luca Cicin-Sain
Interview
In the coronavirus pandemic, older people are particularly at risk from severe courses of COVID-19. However, other infectious diseases also affect them more than younger people. On the occasion of the International Day of Older Persons on 1 October, Prof Luka Cicin-Sain, Head of the Department "Viral Immunology", talks about the ageing of the immune system.
30.09.2021
Logos HZI und EMBL
News
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance scientific progress for human health.
22.09.2021
Einladung
News
On 9 September 2021, the 13th TWINCORE Symposium took place. This year, too, the event was held online due to corona. Nevertheless, the webinar was a great success and attracted even more viewers than last year.
13.09.2021
Schaubild
News
New antibiotics are urgently needed in the fight against multi-resistant bacteria. The recently discovered darobactin is a potential candidate with resistance-breaking properties. This substance shows very good antimicrobial activity against some of the most problematic hospital germs. However, so far darobactin could only be produced in relatively small quantities, making detailed investigation and further development difficult. A team led by Dr Sebastian Groß from the Department of Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken has now addressed this problem. The scientists published their results in the journal Chemical Science.
31.08.2021

HZI in the media

... “

 

Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) untersuchen ...

22.10.2026
|
DeutschesGesundheitsPortal

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

22.10.2026
|
DIE WELT

... befallen. Am HZI in Braunschweig wird daran geforscht.

 

Am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ...

22.10.2026
|
NDR Norddeutscher Rundfunk

are extremely complex.

 

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now shown that artificial

21.10.2026
|
Phys.org

Würzburg (JMU) und dem Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des HZI in ...

20.10.2026
|
Regional Heute

community. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) that operates in collaboration with Saarland University.

20.10.2026
|
WDC Tv News

... Verabreichung eintritt. Expertin Berit Lange vom Helmholtz-Zentrum für Infektionsforschung betonte, dass jetzt der richtige Moment ...

16.10.2026
|
upday

... Berit Lange im Gespräch mit FOCUS online. Sie ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum ...

16.10.2026
|
Focus Online

protection against BV. Researchers from the Helmholtz Centre for Infection Research have reported evidence that antibodies produced after

16.10.2026
|
Medscape

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

16.10.2026
|
Berliner Morgenpost

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network

Register now for the HZI newsletter